Brussels, 02/07/2002 (Agence Europe) - The first results of clinical trials on 11 patients at Basle Kantonspital and tests in the USA on 37 patients confirm the possibility of killing certain types of cancer using isotopes ((bismuth-213 or astatine-211 and actinium-225 alpha emitters). Commissioner Philippe Busquin welcomed these results, which represent the results of co-operation between the Common Research Centre (CRC) and the Institute for Transuranium Elements and the University...